Document is current
Any future updates will be listed below
-
Authors
Sano, Tatsuhiko https://orcid.org/0000-0002-2992-9150
Nagata, Tetsuya https://orcid.org/0000-0003-4111-2693
Ebihara, Satoe
Yoshida-Tanaka, Kie
Nakamura, Ayako
Sasaki, Asuka
Shimozawa, Aki
Mochizuki, Hideki
Uchihara, Toshiki
Hasegawa, Masato
Yokota, Takanori https://orcid.org/0000-0002-6490-3263
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18am0301003h0005)
Japan Agency for Medical Research and Development (23am0401006h0005)
Japan Society for the Promotion of Science (22H00440)
Japan Society for the Promotion of Science (16H05221)
- License Information
-
More Information
Article History
Received: 21 March 2024
Accepted: 26 March 2024
First Online: 14 May 2024
Declarations
:
: All experimental protocols were approved by the Institutional Animal Care and Use Committee of Tokyo Medical and Dental University (Approval Number A2022-085A).
: T.Y. has ongoing collaborations with Takeda Pharmaceutical Co., Ltd. and serves as an academic advisor for Rena Therapeutics Inc. and Nissan Chemical Corporation. The other authors declare no competing interests.
